Mads Agerbæk

Early Detection of Metastatic Relapse and Monitoring of Therapeutic Efficacy by Ultra-Deep Sequencing of Plasma Cell-Free DNA in Patients With Urothelial Bladder Carcinoma

Emil Christensen, Karin Birkenkamp‐Demtröder, Himanshu Sethi et al. · Journal of Clinical Oncology · 2019 · 545 citations · Full text

Medicine, Oncology, Urology +17

Genomic Alterations in Liquid Biopsies from Patients with Bladder Cancer

Karin Birkenkamp‐Demtröder, Iver Nordentoft, Emil Christensen et al. · European Urology · 2016 · 236 citations

Medicine, Genetics, Oncology +16

Surveillance for Stage I Nonseminoma Testicular Cancer: Outcomes and Long-Term Follow-Up in a Population-Based Cohort

Gedske Daugaard, Maria Gry Gundgaard, Mette Saksø Mortensen et al. · Journal of Clinical Oncology · 2014 · 235 citations

Medicine, Oncology, Surgery +16

Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysis

Ann Taber, Emil Christensen, Philippe Lamy et al. · Nature Communications · 2020 · 216 citations · Full text

Life Sciences, Bioinformatics, Oncology +17

A Nationwide Cohort Study of Stage I Seminoma Patients Followed on a Surveillance Program

Mette Saksø Mortensen, Jakob Lauritsen, Maria Gry Gundgaard et al. · European Urology · 2014 · 202 citations

Medicine, Oncology, Disease Surveillance +8